These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


623 related items for PubMed ID: 23330821

  • 1. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F, Tölle M, von der Giet M, Passlick-Deetjen J, Steppan S, Peter M, Jankowski V, Krause A, Kühne S, Zidek W, Jankowski J.
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J, Wang Y, Xu X, Cao W, Shen Z, Wang N, Leng J, Zou N, Shang E, Zhu Z, Guo J, Duan J.
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [Abstract] [Full Text] [Related]

  • 4. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
    Lee CT, Hsu CY, Tain YL, Ng HY, Cheng BC, Yang CC, Wu CH, Chiou TT, Lee YT, Liao SC.
    Blood Purif; 2014 Apr; 37(1):76-83. PubMed ID: 24576840
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O, Van Biesen W, Glorieux G, Massy Z, Dhondt A, Eloot S.
    Toxins (Basel); 2015 Sep 28; 7(10):3933-46. PubMed ID: 26426048
    [Abstract] [Full Text] [Related]

  • 12. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.
    Meijers BK, Weber V, Bammens B, Dehaen W, Verbeke K, Falkenhagen D, Evenepoel P.
    Artif Organs; 2008 Mar 28; 32(3):214-9. PubMed ID: 18201285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S, Yoshida M.
    Toxins (Basel); 2014 Feb 20; 6(2):665-78. PubMed ID: 24561478
    [Abstract] [Full Text] [Related]

  • 18. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y, Cluet Y, Titeca-Beauport D, El Esper N, Ureña P, Bodeau S, Combe C, Dussol B, Fouque D, Choukroun G, Liabeuf S.
    Toxins (Basel); 2019 May 17; 11(5):. PubMed ID: 31109001
    [Abstract] [Full Text] [Related]

  • 19. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O, de Loor H, Glorieux G, Dhondt A, Van Biesen W, Meijers B, Eloot S.
    Biochimie; 2017 Aug 17; 139():20-26. PubMed ID: 28528271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.